Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank44
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P44
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2024-2.38%
2023-7.81%
202246.33%
2021215.59%
2020-5.87%
2019-80.99%
201889.53%
2017-47.24%
2016649.13%
20150.00%